Pharmacoeconomic ABC- and VEN- analyses of treatment of community -acquired pneumonia patients with comorbidities


  • A. V. Demchuk
Keywords: сommunity-acquired pneumonia, ABC-analyses, VEN-analysis, costs

Abstract

The estimation of economic rationality treatment costs of community-acquired pneumonia patients with comorbidities was performed using ABC- and VEN-analyses. It was established financial resources use is partial rational, because most of expenses are used for vital medicines, but non-essential pathogenical drugs for treatment of CAP patients with comorbidities are included into group. These medicines increase treatment cost in average 108,5 UHR/patient without improvement of clinical effectiveness of therapy.

Published
2017-03-31
How to Cite
Demchuk, A. V. (2017). Pharmacoeconomic ABC- and VEN- analyses of treatment of community -acquired pneumonia patients with comorbidities. Biomedical and Biosocial Anthropology, (26), 121-124. Retrieved from https://bba-journal.com/index.php/journal/article/view/149